2018 FDA drug approvals (original) (raw)

The FDA approved a record 59 drugs last year, but the commercial potential of these drugs is lacklustre.

The FDA’s Center for Drug Evaluation and Research (CDER) approved 59 novel drugs in 2018, breaking its record of 53 drugs in 1996 (Fig. 1; Table 1). This bumper approval crop follows on the heels of a few fruitful years for drug developers. The FDA’s 5-year annual average is now 43 drugs per year, nearly twice its nadir in 2009.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Nature Reviews Drug Discovery 18, 85-89 (2019)

doi: https://doi.org/10.1038/d41573-019-00014-x

High-resolution versions of the figures for this article are available as supplementary information.

Supplementary Information

  1. Supplementary information

Subjects

Latest on: